This information was published on 2024-01-10T13:40:13 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2418251 (IR 1770183) |
| (220) |
16 Nov 2023
|
| (300) |
US, 29 Jun 2023, 98065536
|
| (500) |
The mark consists of the word GEn1E with the letters G and E in upper case, dark blue color font and the letter N and number 1 in lower case, light blue color font, and the word LIFESCIENCES underneath in a smaller font, upper case in dark blue color.
The color(s) blue is/are claimed as a feature of the mark. The mark consists of the word GEn1E with the letters G and E in upper case, dark blue color font and the letter N and number 1 in lower case, light blue color font, and the word LIFESCIENCES underneath in a smaller font, upper case in dark blue color. |
| (511) (510) |
Class 42
Artificial intelligence powered novel drug development services. |
| (540) |
|
| (730) |
GEn1E Lifesciences Inc.
|
Find out more about publications on the About page.